https://www.ck-wissen.de/ckwiki/index.php?title=Diskussion:Triptan&feed=atom&action=historyDiskussion:Triptan - Versionsgeschichte2024-03-28T18:48:53ZVersionsgeschichte dieser Seite in CK-WissenMediaWiki 1.39.1https://www.ck-wissen.de/ckwiki/index.php?title=Diskussion:Triptan&diff=4836&oldid=prevFriedrich: Die Seite wurde neu angelegt: == Medikamentenmissbrauch und Medikamenten-induzierter Kopfschmerz == Zitat: "In double-blind, placebo-controlled trials, the 5- HT1B/D agonist sumatriptan 6 mg injec...2007-09-17T10:35:08Z<p>Die Seite wurde neu angelegt: == Medikamentenmissbrauch und Medikamenten-induzierter Kopfschmerz == Zitat: "In double-blind, placebo-controlled trials, the 5- HT1B/D agonist sumatriptan 6 mg injec...</p>
<p><b>Neue Seite</b></p><div>== Medikamentenmissbrauch und Medikamenten-induzierter Kopfschmerz ==<br />
<br />
Zitat:<br />
<br />
"In double-blind, placebo-controlled trials, the 5-<br />
HT1B/D agonist sumatriptan 6 mg injected subcutaneously<br />
is effective in about 75% of all cluster headache<br />
patients (i.e. pain free within 20 min) [38–40]. Doses less<br />
than 6 mg have also been described to be effective [41].<br />
'''It is safe with no evidence of tachyphylaxis or rebound in most of the patients, even after frequent use [42–44], although recent evidence suggests that cluster headache patients with migraine may experience rebound headache [45].'''"<br />
<br />
38. The Sumatriptan Cluster Headache Study Group.<br />
Treatment of acute cluster headache with sumatriptan.<br />
New England Journal of Medicine 1991; 325: 322–326.<br />
<br />
39. Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ,<br />
Noronha D. Subcutaneous sumatriptan in the acute<br />
treatment of cluster headache: a dose comparison study.<br />
The Sumatriptan Cluster Headache Study Group. Acta<br />
Neurologica Scandinavica 1993; 88: 63–69.<br />
<br />
40. Stovner LJ, Sjaastad O. Treatment of cluster headache<br />
and its variants. Current Opinion in Neurology 1995; 8:<br />
243–247.<br />
<br />
41. Gregor N, Schlesiger C, Akova-Ozturk E, Kraemer C,<br />
Husstedt IW, Evers S. Treatment of cluster headache<br />
attacks with less than 6 mg subcutaneous sumatriptan.<br />
Headache 2005; 45: 1069–1072.<br />
<br />
42. Wilkinson M, Pfaffenrath V, Schoenen J, Diener HC,<br />
Steiner TJ. Migraine and cluster headache – their<br />
management with sumatriptan: a critical review of the<br />
current clinical experience. Cephalalgia 1995; 15: 337–<br />
357.<br />
<br />
43. Ekbom K, Krabbe A, Micelli G, et al. Cluster headache<br />
attacks treated for up to three months with subcutaneous<br />
sumatriptan (6 mg). Sumatriptan Cluster Headache<br />
Long-term Study Group. Cephalalgia 1995; 15: 230–236.<br />
<br />
44. Go¨ bel H, Lindner V, Heinze A, Ribbat M, Deuschl G.<br />
Acute therapy for cluster headache with sumatriptan:<br />
findings of a one-year long-term study. Neurology 1998;<br />
51: 908–911.<br />
<br />
45. Paemeleire K, Bahra A, Evers S, Matharu M, Goadsby<br />
P. Medication-overuse headache in cluster headache patients.<br />
Neurology 2006; 67: 109–113.<br />
<br />
46. Dodick DW, Martin VT, Smith T, Silberstein S. Cardiovascular<br />
tolerability and safety of triptans: a review of<br />
clinical data. Headache 2004; 44(Suppl. 1): S20–S30.<br />
<br />
<br />
Quelle: http://www.efns.org/files/guideline_49.pdf<br />
<br />
--[[Benutzer:Friedrich|Friedrich]] 12:35, 17. Sep. 2007 (CEST)</div>Friedrich